Enjoy complimentary customisation on priority with our Enterprise License!
The Cardiovascular and Soft Tissue Repair Patches Market size is estimated to grow by USD 1.99 billion at a CAGR of 8.09% between 2023 and 2028. Myocardial infarction (MI), along with other cardiovascular problems, is becoming prevalent in the majority of the population. This increasing prevalence of coronary artery disease, obesity, diabetes, hypertension, a sedentary lifestyle, smoking, and reduced physical activities are expected to fuel the risk factors for cardiovascular diseases such as MI. Hence, such factors are expected to drive the requirement for cardiovascular and soft tissue repair patches, which, in turn, will positively impact market growth.
To learn more about this report, Request Free Sample
The soft tissue repair segment is estimated to witness significant growth during the forecast period. There is a rise in demand for the soft tissue repair segment due to the increasing prevalence of cardiovascular disorders over the past decade. Hypercholesterolemia is a risk factor for cardiovascular diseases that increases the chances of acquiring cardiovascular diseases of atherosclerotic origin. Atherosclerosis is a severe medical condition that impacts the arteries that supply blood to the heart.
Get a glance at the market contribution of various segments View a PDF Sample
The soft tissue repair segment was the largest and was valued at USD 1.30 billion in 2018. Atherosclerosis is one of the main causes of use of coronary artery disease and is described as a plaque inside the artery or vessel wall. The main component of plaque is cholesterol which increases the risk of developing atherosclerosis. Hypercholesterolemia is the main cause of developing atherosclerosis and it has no symptoms. As a result, the majority of people are unaware of the condition. Hence, due to the increasing prevalence of hypercholesterolemia. It is expected to drive the growth of this segment which in turn will drive the global market during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors driving the market in North America is the factors such as the increasing incidence of MI and the availability of reimbursement schemes. Some of the key factors leading to the increasing prevalence of MI include obesity, diabetes, high blood pressure, smoking, hereditary, stress, and illicit drugs. Furthermore, the use of drugs among the US population is also significantly contributing to the market growth in the region. Additionally, several factors, such as the rising geriatric population in the US and increasing support from the government for people to have treatments at affordable prices, are expected to drive the market growth in the region during the forecast period.
The market encompasses the production, sales, and distribution of patches used in the repair of cardiovascular and soft tissue damage. These patches are utilized in various clinical procedures, including cardiac procedures, to address conditions such as Congenital Heart Diseases, Atrial Septal Defect, Ventricular septal defect, Hernias (including Inguinal Hernias, Ventral hernias, and Umbilical hernias), and other tissue damage. The market is driven by the growing need for minimally invasive procedures and the development of advanced tissue engineering regenerative, such as Eptfe and bovine pericardium. The market is witnessing significant growth due to the increasing number of elective surgical procedures and the rising prevalence of hernia disorders. The use of these patches in the repair of congenital heart diseases and other cardiovascular conditions is also on the rise, as they offer a less invasive alternative to traditional surgical procedures. Public-private partnerships and collaborations between raw material suppliers and market players are expected to further propel the growth of the market. The market trends reflect the emphasis on healthcare trends and the ongoing advancements in surgical procedures, leading to the development of innovative solutions like bionic heart patches.
The market growth is fuelled by the escalating incidence of MI. Factors such as coronary artery disease, obesity, diabetes, hypertension, sedentary lifestyle, smoking, and reduced physical activities are amplifying the risk of cardiovascular diseases, notably MI. According to the Centers for Disease Control and Prevention (CDC), nearly half of Americans possess at least one of these risk factors, with approximately 790,000 Americans suffering from a heart attack annually.
Moreover, the burgeoning geriatric demographic significantly contributes to market expansion. Aging correlates with a decline in vital physiological components and antioxidants, leading to cellular, tissue, and molecular damage. Consequently, the prevalence of diseases rises. These trends are anticipated to propel market growth, offering diverse application niches, obtaining product approvals, and facilitating informed market decisions.
Advances in diagnostic modalities are a major trend in the market. The main two components that are used for diagnosing heart diseases such as MI include the pathological component and the clinical component. The pathological component highly depends on evidence indicating myocardial cell death, whereas the clinical component relies on electrocardiographic, biochemical, and imaging modalities for diagnosing MI. There is a significant improvement in the diagnostic methods for heart disorders such as MI due to several advancements in technology.
As a result, it helps in better assessments of physiological and biochemical alterations. Furthermore, imaging modalities have also helped in the early diagnosis of MI and related cardiovascular problems. Hence, such benefits are expected to drive the global cardiovascular and soft tissue repair patch market growth during the forecast period.
The lack of skilled cardiac surgeons is a major challenge restraining market growth. There has been a rapid change in surgical training over time and is significantly challenged by ethical and legal concerns for patient safety. There is a shortage of skilled highly skilled surgeons, physicians, and technicians in both developing and developed countries which is leading to a demand-supply gap.
One of the key reasons for this demand-supply cap is due to an increase in the number of experienced healthcare professionals who are nearing retirement. The scarcity of qualified laboratory personnel and surgeons will increase the complications and risks during surgeries. For instance, there is a significant shortage of cardiac surgeons in developing economies like India. Hence, such factors are expected to hinder the market growth during the forecast period.
The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:
B.Braun SE: The company offers cardiovascular soft tissue repair patches called DurAVR TAVR system, which is in the clinical trial phase of development.
Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
The market is designed to address various conditions, including hernias and heart diseases. These patches play a crucial role in tissue repairing procedures, particularly in cardiac and clinical procedures. The market for these patches is witnessing significant growth due to the increasing incidence rate of congenital heart diseases and the need for minimally invasive procedures. Cardiovascular patches are used in the repair of cardiac procedures, such as Atrial Septal Defect and Ventricular septal defect. Soft tissue repair patches are used for dural repair, vascular repair, cardiac repair and hernia disorders, including Congenital Diaphragmatic Hernias, Inguinal Hernias, Ventral hernias, and Umbilical hernias. The regulatory framework for these patches is stringent, ensuring the use of high-quality raw materials, such as EPTFE and bovine pericardium. Tissue engineering materials, like bionic heart patches, are also gaining popularity due to their ability to promote tissue regeneration. The healthcare trends towards early diagnosis and elective surgical sutures are driving the demand for cardiovascular and soft tissue repair patches.
The market is expected to continue its growth trajectory, with surgical procedures, such as pericardial repair and surgical sealant, playing a significant role in its expansion. Robotic implant technology is also expected to influence the market, offering advantages in terms of precision and minimally invasive procedures. The market is growing due to increasing long-term morbidity from congenital heart disease, including congenital atrial septal defects and congenital ventricular septal defects. Advanced treatment options such as the bionic heart patch are transforming clinical implementation of medical devices. This market addresses cardiac diseases, coronary heart disease, and hernia disorder, with innovative solutions for treatment for hernias and soft tissue disorders. Rising healthcare expenditure and evolving patient epidemiology underscore the need for effective therapies. The integration of these therapeutic strategies into healthcare aims to improve outcomes in cardiac diseases and beyond.
Market Scope |
|
Report Coverage |
Details |
Page number |
157 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.09% |
Market Growth 2024-2028 |
USD 1.99 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.32 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Aegis Lifesciences Pvt. Ltd., Anteris Technologies Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Braile Biomedica, CorMatrix Inc., Edwards Lifesciences Corp., Glycar SA, Integra Lifesciences Corp., Labcor Laboratorios Ltda., LeMaitre Vascular Inc., Maverick Biosciences Pty Ltd., Shockwave Medical Inc., Tisgenx Inc., Vascudyne Inc., and W. L. Gore and Associates Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Raw Material
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.